Elutia ELUT
NASDAQ ELUT
$0.81 +0.01 (+1.76%)
As of: Sep 10, 2026 · 1:49 PM EDT

Elutia (ELUT) Revenue Growth (3y) (2022 - 2026)

Analysis

Elutia (ELUT) Revenue Growth (3y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 180.79 Bn 175.19 Bn 7.27 Bn 8.07%
2 Intuitive Surgical 127.05 Bn 121.83 Bn 1.96 Bn 18.10%
3 Medtronic 117.00 Bn 108.18 Bn 6.34 Bn 8.20%
4 Stryker 103.78 Bn 100.31 Bn 4.50 Bn 9.66%
5 Boston Scientific 63.50 Bn 62.96 Bn 3.85 Bn 14.78%
6 Edwards Lifesciences 49.72 Bn 45.46 Bn 1.35 Bn 10.83%
7 Alcon 32.98 Bn 31.52 Bn 1.68 Bn 4.73%
8 Dexcom 32.05 Bn 30.10 Bn 830.00 Mn 14.51%
9 Steris 20.68 Bn 20.19 Bn 684.20 Mn 8.05%
10 Elutia 36.01 Mn 16.11 Mn 1.45 Mn -27.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.43%
Mar 31, 2026 -21.31%
Dec 31, 2025 -20.81%
Sep 30, 2025 -17.18%
Jun 30, 2025 -39.87%
Mar 31, 2025 -36.44%
Dec 31, 2024 -36.23%
Sep 30, 2024 -31.68%
Jun 30, 2024 -19.72%
Mar 31, 2024 -19.61%
Dec 31, 2023 -22.18%
Sep 30, 2023 -19.57%
Jun 30, 2023 -9.54%
Mar 31, 2023 -13.46%
Dec 31, 2022 -18.24%
Sep 30, 2022 -19.32%